Tagliaferri Maryinsider trades

In SEC Form 4 filings, Tagliaferri Mary is listed as Director of Iambic Therapeutics, Inc. (IAM). Tagliaferri Mary reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 16.

Companies and roles

Company	Role	Transactions	Last filed
IAMIambic Therapeutics, Inc.	Director	1	Oct 16

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-16

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
IAMIambic Therapeutics, Inc.	Oct 14	Oct 16	A · derivative	20,300	$16.00	$324,800	20,300	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.